Want to join the conversation?
$GILD's research and development expenses for 3Q15 rose by 18% from last year, on $77MM related to clinical study activity, particularly due to continued progression of clinical studies in HIV TAF-based programs. Selling, general and administrative expenses fell by 4% on $197MM decline in non-tax deductible branded prescription drug fee.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!